Stay updated on Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated on the page, replacing the prior v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:28:53.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the notices about funding lapse and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T02:16:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center’s status was added, directing users to updated information. The site version was updated from Revision: v3.4.0 to Revision: v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:04:43.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle, Last Update Submitted that Met QC Criteria label, No FEAR Act Data label, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T23:42:59.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:46:45.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section listing Massachusetts as a study location; the revision updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:22:21.000Z thumbnail image

Stay in the know with updates to Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Oral Proliferative Verrucous Leukoplakia Clinical Trial page.